España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Haleon
HLN
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$9.39
0.08
0.86%
At close: -
$9.39
0
0.00%
After Hours: 4:37 PM EDT
Get Report
Comment
Haleon (HLN) Forecast
News
Earnings
Haleon (HLN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Haleon (NYSE:HLN) Stock
Haleon Stock (NYSE: HLN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, November 04, 2024
Haleon Selects Vistar Media As Preferred Glob...
Benzinga Newsdesk
Monday, October 21, 2024
What's Going On With Kenvue Stock Monday?
Dylan Berman
Friday, October 11, 2024
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
Vandana Singh
Tuesday, October 01, 2024
Pfizer Divests $3.3B Stake In Sensodyne Toothpaste And Panadol Painkiller Maker Haleon
Kaustubh Bagalkote
Monday, September 30, 2024
Pfizer Boosts Haleon Offering Size To 640M Sh...
Benzinga Newsdesk
Pfizer Intends To Sell About 540M Ordinary Sh...
Benzinga Newsdesk
Wednesday, September 25, 2024
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
Vandana Singh
Friday, September 20, 2024
Morgan Stanley Maintains Overweight on Haleon...
Benzinga Newsdesk
Monday, September 16, 2024
PubMatic Joins Forces with Haleon to Optimize...
Benzinga Newsdesk
Tuesday, September 03, 2024
Haleon Launches Eroxon In U.S. Preorder Witho...
Benzinga Newsdesk
Friday, August 09, 2024
Top 2 Risk Off Stocks That May Implode In August
Avi Kapoor
Thursday, August 01, 2024
Haleon Reiterated FY24 Organic Revenue Growth...
Benzinga Newsdesk
Haleon H1 Sales $7.231B Miss $8.641B Estimate
Benzinga Newsdesk
Thursday, June 27, 2024
Dr. Reddy's to Acquire Haleon's Nicotine Addiction Drug
Zacks
Wednesday, June 26, 2024
Haleon To Offload Non-Core Nicotine Therapy Business To Dr. Reddy's For Over $600M
Vandana Singh
Haleon Sells Its Nicotine Replacement Therapy...
Benzinga Newsdesk
Dr. Reddy's To Acquire Haleon's Global Portf...
Benzinga Newsdesk
Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC
Vandana Singh
Friday, May 17, 2024
GSK Completely Exits Sensodyne Toothpaste Maker Haleon In $1.6B Sale
Vandana Singh
Thursday, May 16, 2024
GSK Announces Intention To Sell ~385M Shares ...
Benzinga Newsdesk
Wednesday, May 01, 2024
Haleon Q1 2024 GAAP EPS £9.20 Beats £8.85 Est...
Benzinga Newsdesk
Wednesday, April 24, 2024
Haleon Appoints Dawn Allen As CFO, After Tobi...
Benzinga Newsdesk
Tuesday, March 26, 2024
Argus Research Maintains Buy on Haleon, Maint...
Benzinga Newsdesk
Monday, March 18, 2024
Haleon shares are trading lower after Pfizer ...
Benzinga Newsdesk
Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon, Potentially Worth £2B
Vandana Singh
Thursday, February 29, 2024
Advil Maker Haleon Expects Higher 2024 Revenue After Strong 2023 Earnings, Stock Soars
Vandana Singh
Haleon shares are trading higher. The company...
Benzinga Newsdesk
Earnings Scheduled For February 29, 2024
Benzinga Insights
Haleon Expects FY24 Organic Revenue Growth Of...
Benzinga Newsdesk
Haleon FY Sales $14.03B Miss $14.47B Estimate
Benzinga Newsdesk
Wednesday, February 28, 2024
Haleon Earnings Preview
Benzinga Insights
Thursday, January 25, 2024
Robitussin Recall: Here Are The Products Impacted And What You Need To Know
Aaron Bry
Yellow Wood Partners' Suave Brands To Acquire...
Benzinga Newsdesk
Wednesday, January 17, 2024
GSK Cuts More Stake In Its Spun-Off Consumer-Healthcare Business Haleon, Raises Over £900M
Vandana Singh
Tuesday, January 16, 2024
GSK Announces Intention To Sell Approximately...
Benzinga Newsdesk
Peering Into Haleon's Recent Short Interest
Benzinga Insights
Thursday, December 28, 2023
How Is The Market Feeling About Haleon?
Benzinga Insights
Friday, December 01, 2023
Looking Into Haleon's Recent Short Interest
Benzinga Insights
Thursday, November 16, 2023
Major Buyout Firms Eye Sanofi's Consumer Health Division Spinoff Valued Over $20B
Vandana Singh
Wednesday, November 15, 2023
How Is The Market Feeling About Haleon?
Benzinga Insights
Wednesday, November 01, 2023
Morgan Stanley Initiates Coverage On Haleon w...
Benzinga Newsdesk
Monday, October 30, 2023
A Look Into Haleon Inc's Price Over Earnings
Benzinga Insights
Friday, October 27, 2023
Sanofi Goes The Rival Way: Plans Separation Of Consumer Healthcare Unit
Vandana Singh
Tuesday, October 24, 2023
How Is The Market Feeling About Haleon?
Benzinga Insights
Friday, October 06, 2023
Regulatory Shadow Over Saudi Golf League LIV And PGA Tour Merger, Novo Nordisk's Weight Loss Drugs May Pose Serious Stomach Risks, Netflix's Local Content and Pricing Woes Undermine Growth in India: Today's Top Stories
Vandana Singh
GSK Cuts Stake In Consumer Healthcare Business Haleon, Raises Around $1B
Vandana Singh
Thursday, October 05, 2023
GSK Announces Intention To Sell 270M Shares I...
Benzinga Newsdesk
How Is The Market Feeling About Haleon plc American Depositary Shares (Each representing two Ordinary Shares)?
Benzinga Insights
Friday, September 15, 2023
Peering Into Haleon's Recent Short Interest
Benzinga Insights
Tuesday, September 12, 2023
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
Vandana Singh
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
